Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 2/3 2 Phase NA 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3856 Neoplasms 2988 Prostatic Neoplasms 1751 Colorectal Neoplasms 1426 Lung Neoplasms 1327 Motor Activity 802 Head and Neck Neoplasms 683 Pancreatic Neoplasms 662 Colonic Neoplasms 655 Uterine Cervical Neoplasms 648 Carcinoma, Non-Small-Cell Lung 629 Carcinoma, Hepatocellular 628 Rectal Neoplasms 569 Stomach Neoplasms 544 Brain Neoplasms 483 Ovarian Neoplasms 438 Anxiety Disorders 419 Pain 418 Neoplasm Metastasis 385 Esophageal Neoplasms 384 Polycystic Ovary Syndrome 374 Precursor Cell Lymphoblastic Leukemia-Lymphoma 354 Urinary Bladder Neoplasms 351 Fatigue 339 Melanoma 322 Multiple Myeloma 320 Lymphoma 305 Depression 305 Endometrial Neoplasms 289 Liver Neoplasms 279

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Interventional × Lymphangioma × Clear all

NCT06892964 2025-03-25

IReg-LM

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase NA Recruiting

Lymphangioma, Lymphatic Abnormalities

Data powered by HemOnc (CC BY 4.0) Colophon ⚡